RMC Pharmaceutical Solutions Email Format
Biotechnology ResearchColorado, United States11-50 Employees
RMC Pharmaceutical Solutions is a biotechnology research firm based in Longmont, Colorado, that became part of Syner-G BioPharma Group in January 2023. The acquisition expanded its capabilities to include process and analytical development, regulatory strategy, regulatory submission support, and quality management services for biotechnology and pharmaceutical programs. Through the combination, clients gain access to an integrated development and regulatory services pathway for CMC activities across organizations of varying size on a global scale. RMC serves pharmaceutical and biotechnology customers seeking support across development and regulatory workflows, addressing process development, analytical development, regulatory strategy, submission efforts, and quality systems. Positioned in the biotechnology research sector, it operates as part of a broader group delivering integrated development and regulatory services for life-science programs worldwide. In June 2026, Syner-G BioPharma Group launched 3D Intelligence, a people-centered AI transformation service for biopharma, illustrating the group's ongoing expansion of capabilities.